Policy Brief 80
by Sachin Chaturvedi, Dominic Glover and Ian Scoones
January 2016
The success of India’s generic pharmaceuticals industry is seen by some policymakers as a success for international development and cooperation, bringing affordable drugs to populations not only in India itself but across the developing world, including in Africa.
Could India’s thriving seed sector play a similar role for affordable, high quality seeds? How comparable are India’s pharmaceuticals and seed sectors in reality? And what lessons could be learned from the pharma case that might be relevant to the seed sector? In this briefing note we explore these questions.
